Pacifico National, Inc. dba AmEx Pharmacy
FDA Regulatory Profile
Summary
- Total Recalls
- 5 (2 Class I)
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-1849-2019 | Class II | Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repa | August 30, 2019 |
| D-1850-2019 | Class II | Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repac | August 30, 2019 |
| D-1271-2019 | Class II | BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repack | April 19, 2019 |
| D-0869-2016 | Class I | Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabet | January 20, 2015 |
| D-0870-2016 | Class I | Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Eliza | January 20, 2015 |